Drug therapy of arterial hypertension
Rahn, K.H.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 93: 241-246
1987
ISSN/ISBN: 0070-4067 PMID: 3442103 Document Number: 290768
Document emailed within 1 workday
Related Documents
Tepel, M. 1999: Drug therapy of arterial hypertension Der Internist 40(12): 1334-1336Aschermann, M.; Jansa, P. 2014: Drug therapy of pulmonary arterial hypertension in 2014 Vnitrni Lekarstvi 60(4): 282-288
Salvetti, A.; Virdis, A.; Di Venanzio, L. 1993: The rationale for drug combinations in the therapy of arterial hypertension Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 8 Suppl: 107s-110s
Benvenuti, C.; Guerini Rocco, C.; Trezzi, P. 1995: Nationwide drug surveillance project on slow-release nicardipine in the short-term therapy of light/moderate arterial hypertension Minerva Cardioangiologica 43(9): 399-408
Zapesochnaia, I.L.; Avtandilov, A.G. 2014: The influence of combined therapy with calcium antagonist and angiotensin-converting enzyme inhibitor on the circadian profile of arterial pressure in patients with arterial hypertension in the Far North Klinicheskaia Meditsina 92(10): 33-40
Dworak, N.; Guelpa, G.; Robert, D. 1990: Drug-induced arterial hypertension Revue Medicale de la Suisse Romande 110(12): 1027-1031
Kawecka-Jaszcz, K.; Skoczeń, M. 1987: Nifedipine as an emergency drug in arterial hypertension Przeglad Lekarski 44(2): 285-287
Van Zwieten, P.A. 1980: Modern concepts in the drug treatment of arterial hypertension International Journal of Clinical Pharmacology Therapy and Toxicology 18(9): 412-419
Krzesinski, J.M. 2009: How to manage an arterial hypertension resistant to drug treatment Revue Medicale de Liege 64(3): 171-175
2008: Aliskiren: new drug. Arterial hypertension: no evidence of clinical efficacy Prescrire International 17(94): 47-50
Pellegrino, L.; Prencipe, G. 1995: Ultrasonography of the carotid arteries in mild-to-moderate essential arterial hypertension and isolated systolic arterial hypertension Cardiologia 40(2): 109-116
Pannarale, G.; Mazzesi, G.; Gaspardone, A.; Casadio, C.; Scopinaro, F.; Greco, C. 1982: Severe pulmonary arterial hypertension in drug addicts: etiopathogenetic considerations Cardiologia 27(2): 185-192
Borovkov, N.N.; Sidorova, N.V. 2002: 24-hour arterial hypertension profile and heart rhythm variability in patients with arterial hypertension and NIDDM Klinicheskaia Meditsina 80(7): 19-21
Cerasola, G.A.; Botta, R.M.; Riolo, A.; Amico, L.M. 1979: Efficacy of a new beta-blocking drug (atenolol, ICi 66082) in treating arterial hypertension Bollettino Della Societa Italiana di Cardiologia 24(5): 493-500
Piñeiro, F.; Gil, V.; Donis, M.; Orozco, D.; Pastor, R.; Merino, J. 1997: The validity of 6 indirect methods for assessing drug treatment compliance in arterial hypertension Atencion Primaria 19(7): 372-374; 376
Cloix, J.F.; Devynck, M.A.; Meyer, P. 1982: Plasma protein changes in essential arterial hypertension: a new genetic marker for arterial hypertension? Annales de Pediatrie 29(9): 655-656
Gürke, T. 1998: Therapy refractory arterial hypertension Praxis 87(48): 1662-1663
Maschio, G.; Valvo, E.; Bedogna, V.; Panebianco, R.; Casagrande, P. 1988: Therapy of arterial hypertension in diabetes Giornale di Clinica Medica 69(5): 323-328
Mamedov, M.N. 2004: Arterial hypertension in a framework of metabolic syndrome: special features and principles of drug correction Kardiologiia 44(4): 95-100
Bellini, G.; Faccini, L.; Battilana, G.; Carretta, R.; Rigoni, A.; Puppis, E.; Rustia, R.; Englaro, E.; Carraro, M.; Fabris, B.; Menchini, U. 1981: Captopril in the treatment of arterial hypertension. Studies of the therapeutic effectiveness and the alleged nephrotoxicity of the drug Giornale di Clinica Medica 62(11): 789-800